Biomarkers in heart failure with preserved ejection fraction
Biomarkers are widely used and studied in heart failure. Most studies have described the utility and performance of biomarkers in sub-studies of randomised clinical trials, where the vast majority of the patients suffered from heart failure with reduced ejection fraction (HFrEF), and not with preser...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bohn Stafleu van Loghum
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796059/ |